Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001061414 | SCV001226157 | uncertain significance | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 322 of the AIP protein (p.Ala322Val). This variant is present in population databases (rs267606586, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with AIP-related conditions. ClinVar contains an entry for this variant (Variation ID: 41216). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt AIP protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Ambry Genetics | RCV002371818 | SCV002689123 | likely benign | Hereditary cancer-predisposing syndrome | 2023-07-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Gene |
RCV000034115 | SCV000058045 | not provided | Somatotroph adenoma | no assertion provided | literature only | ||
| Prevention |
RCV004748542 | SCV005352953 | uncertain significance | AIP-related disorder | 2024-07-15 | no assertion criteria provided | clinical testing | The AIP c.965C>T variant is predicted to result in the amino acid substitution p.Ala322Val. This variant was reported as a variant of uncertain significance in a patient with breast cancer diagnosed before age 45 (DataSheet 1, Gifoni et al 2022. PubMed ID: 35957908). This variant is reported in 0.0074% of alleles in individuals of European (non-Finnish) descent in gnomAD and is interpreted as a variant of uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/41216/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |